Cargando…

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma

Glioma is well known as the most aggressive and prevalent primary malignant tumor in the central nervous system. Molecular subtypes and prognosis biomarkers remain a promising research area of gliomas. Notably, the aberrant expression of mesenchymal (MES) subtype related long non-coding RNAs (lncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Kebing, Yue, Xiaoyu, Zheng, Yinfei, Zhang, Zhengwei, Cheng, Meng, Li, Lianxin, Chen, Zhigang, Yang, Zhihao, Bian, Erbao, Zhao, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446619/ https://www.ncbi.nlm.nih.gov/pubmed/34540695 http://dx.doi.org/10.3389/fonc.2021.726745

Ejemplares similares

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
por: Yang, Zhihao, et al.
Publicado: (2022)

Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma
por: Li, Lianxin, et al.
Publicado: (2022)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
por: Yang, Zhihao, et al.
Publicado: (2023)

Identification of a mesenchymal-related signature associated with clinical prognosis in glioma
por: Zhang, Zhengwei, et al.
Publicado: (2021)

Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
por: Bian, Erbao, et al.
Publicado: (2021)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

Mechanisms of long non-coding RNAs in biological phenotypes and ferroptosis of glioma
por: Yin, Xianyong, et al.
Publicado: (2022)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy
por: Yang, Zhihao, et al.
Publicado: (2020)

A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma
por: Bian, Erbao, et al.
Publicado: (2019)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma
por: Qiu, Xiaowei, et al.
Publicado: (2021)

Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes
por: Tian, Wei, et al.
Publicado: (2022)

Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review
por: Momtazmanesh, Sara, et al.
Publicado: (2021)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Identification of the Prognostic Signatures of Glioma With Different PTEN Status
por: Zhang, Pei, et al.
Publicado: (2021)

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer
por: Saus, Ester, et al.
Publicado: (2016)

A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma
por: Xia, Pengfei, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study
por: Chen, Ming, et al.
Publicado: (2021)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference
por: Zhang, Meng, et al.
Publicado: (2021)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer
por: Wan, Jiaming, et al.
Publicado: (2021)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
por: Chen, Junliang, et al.
Publicado: (2023)

Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022)

Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment
por: Qin, Jie, et al.
Publicado: (2021)

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
por: Chen, Zhigang, et al.
Publicado: (2023)

Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer
por: Boloix, Ariadna, et al.
Publicado: (2019)

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
por: Lu, Cuicui, et al.
Publicado: (2021)

A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs
por: Hu, Jintao, et al.
Publicado: (2022)

A novel melanoma prognostic model based on the ferroptosis-related long non-coding RNA
por: Rao, Yamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o85q1tbtf4q2l1uv2gh6h7nvs1